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Liposome-based drug delivery systems hold great potential for cancer therapy. However, to enhance the localization of
payloads, an efficient method of systemic delivery of liposomes to tumor tissues is required. In this study, we developed
cationic liposomes composed of polyethylenimine (PEI)-conjugated distearoylglycerophosphoethanolamine (DSPE)
as an enhanced local drug delivery system. The particle size of DSPE-PEI liposomes was 130 ± 10 nm and the zeta
potential of liposomes was increased from −25 to 30 mV by the incorporation of cationic PEI onto the liposomal
membrane. Intracellular uptake of DSPE-PEI liposomes by tumor cells was 14-fold higher than that of DSPE liposomes.
After intratumoral injection of liposomes into tumor-bearing mice, DSPE-PEI liposomes showed higher and sustained
localization in tumor tissue compared to DSPE liposomes. Taken together, our findings suggest that DSPE-PEI liposomes
have the potential to be used as effective drug carriers for enhanced intracellular uptake and localization of anticancer
drugs in tumor tissue through intratumoral injection.
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Liposome-based approaches, which show great potential
for cancer therapy, allow for the development of a broad
armamentarium of targeted drugs [1-3]. However, one of
the key challenges in the application of liposomal drug
delivery for chemotherapy is the requirement of efficient
drug localization in tumor tissue. These liposomal systems
are normally injected intravenously for systemic applica-
tion. The effectiveness of intravenously delivered lipo-
somes, however, is plagued by problems such as rapid
opsonization and uptake by the reticuloendothelial system
(RES), resulting in inefficient delivery [4-6]. Therefore,
novel delivery systems to overcome such limitations are
thus in urgent need.
Under localized conditions, drug delivery systems for-
mulated to deliver high concentration of drugs over an
extended period could be an ideal strategy to maximize
the therapeutic benefit and avoid possible side effects* Correspondence: hanhd@kku.ac.kr; bcshin@krict.re.kr
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in any medium, provided the original work is p[7]. However, because low molecular weight drugs can
rapidly pass into the bloodstream after intratumoral in-
jection and because the retention time of such drugs in
tumors is considerably short, new strategies to enhance
the drug delivery and therapeutic effects in tumor tissues
are needed.
In this study, we present a novel method for drug de-
livery using polyethylenimine (PEI)-incorporated cat-
ionic liposomes, which can be injected directly into the
tumor site. PEI is a synthetic cationic polymer that has
been extensively used to deliver oligonucleotides, siRNA,
and plasmid DNA in vitro and in vivo [8-10]. Moreover,
the cationic charge of the carrier surface can be en-
hanced through the intracellular uptake of vehicles to
negatively charged tumor cells or tissues [11-13]. After
penetration of cationic PEI liposomes into the cells, PEI
has a protonatable nitrogen atom, which enables the ‘pro-
ton sponge’ effect over a wide range of pHs in the endo-
some. Consequently, PEI buffers acidification within the
endosome after endocytosis, resulting in osmotic swelling
and cell rupture allowing for endosomal escape of the
PEI/siRNA polyplexes [14]. Although cationic PEI has
promising potential as a vehicle, it also presents some ofOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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tors [15,16]. PEI can, however, be modified for reduced
toxicity, and its free amine groups can be used to conju-
gate cell binding or targeting ligands [17-19]. Therefore,
we selected PEI to increase localization of liposomes in
tumor micro-environment in this study.
Cationic liposomes can also be simply injected at the
target site without the need for surgical procedures. The
PEI-incorporated cationic liposomes system, thus, has
the potential to enhance the concentrations of thera-
peutic payloads at the tumor site, minimize possible side
effects, and ultimately increase the therapeutic index of
therapies. Although many cancers metastasize, several
types of external cancers such as skin, breast, or neck
cancer may be amenable to treatment using DSPE-PEI
liposomes. Here, we demonstrate that the anticancer
drug delivery system based on cationic liposomes is po-




Polyethylenimine (PEI, MW, 600 g/mol), glutaric anhyd-
ride (GA), 1-[3-(dimethylamino) propyl]-3-ethylcarbodii-
mide hydrochloride (EDC), and N-hydroxy-succinimide
(NHS) were purchased from Sigma Aldrich Co. (Milwaukee,
WI, USA). Chemicals 1,2-distearoyl-sn-glycero-3-phos-
phoethanolamine (DSPE), L-α-phosphatidylcholine (soy-
hydrogenated) (HSPC), and cholesterol (CHOL) were
purchased from Avanti Polar Lipids Inc. (Alabaster, AL,
USA). The anticancer drug doxorubicin (DOX) was ob-





Figure 1 Chemical structure (A) and 1H-NMR spectra (B) of synthesizecalcein was purchased from Sigma Co. (St. Louis, MO,
USA). All other materials and solvents were of analyt-
ical grade and used without further purification.
Synthesis of DSPE-PEI
DSPE-PEI conjugate was synthesized according to methods
described in our previous study with a minor modification
[20]. To prepare carboxylated PEI (PEI-co), 1 mmol of PEI
(MW 10 kDa) was dissolved in 50 ml of methylene chlor-
ide (MC) solution, which was then added to 0.1 mmol of
GA (dissolved in 10 ml of MC) solution, followed by
refluxing at room temperature for 10 h. MC was then re-
moved using a rotary evaporator at 20°C to produce car-
boxylated PEI-co (Figure 1A). To synthesize carboxylated
PEI-co and DSPE, PEI-co (0.5 g, 0.83 mmol) and EDC
(0.83 mmol) were treated with NHS (0.83 mmol) in 50 ml
of chloroform at 27°C for 30 min. DSPE (0.83 mmol) was
dissolved in 20 ml of chloroform and then mixed with the
PEI-co solution for conjugation of DSPE via amide linkage
at 27°C for 10 h. After synthesis of DSPE-PEI, the residual
chloroform was removed by rotary evaporator at 20°C. Fol-
lowing synthesis, DSPE-PEI was purified via dialysis for 2
days at 4°C using cellulose dialysis tubing (MWCO 12000,
Viskase Co., Darien, IL, USA). DSPE-PEI powder was ob-
tained through a lyophilization process using a freeze-dryer
(Ilshin Lab Co., Korea) and stored at 4°C until use. The
chemical structure of synthesized DSPE-PEI is shown in
Figure 1A.
Preparation of liposomes
DOX-loaded cationic liposomes were prepared using the
remote loading method by employing ammonium sulfate(1)
(2)
d DSPE-PEI.
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(DSPE) and DSPE-PEI liposomes were HSPC/CHOL (4 mg
of lipid) and HSPC/CHOL/DSPE-PEI (0.1 mg, 0.4 mg,
0.7 mg, and 1 mg of DSPE-PEI based on HSPC/CHOL
formulation), respectively. Lipids were dissolved in
chloroform, dried on a thin film on a rotary evaporator
(Buchi Rotavapor R-200, Switzerland), and finally sus-
pended in a 250 mM of ammonium sulfate solution.
The liposomal solution was extruded by passing it
through a polycarbonate filter (pore size, 100 nm,
Whatman, Piscataway, NJ, USA) using an extruder
(Northern Lipids Inc., Burnaby, Canada). Free ammo-
nium sulfate was removed by dialysis for 48 h at 4°C
using cellulose dialysis tubing (MWCO 3500, Viskase
Co., Darien, USA). The liposomal solution was mixed
with a 2 mg/ml DOX solution and incubated for 2 h at
60°C after which the mixture was dialyzed to facilitate
the removal of free DOX. DOX-loaded liposomes were
stored at 4°C until use. In addition, to DOX-loaded li-
posomes, calcein-loaded liposomes were prepared for
assessment of the localization in tumor-bearing mice.
Calcein-loaded liposomes with the above-mentioned
compositions were prepared by loading calcein serving
as a model drug in liposomes using the pH gradient
method [23].
The particle size and zeta potential of liposomes were
measured by laser light scattering using a particle size
analyzer (ELS-8000, Outskate, Seongnam, South Korea).
The loading efficiency of DOX into liposomes was
measured by fluorescence spectrophotometry (Barnstead,
Apogent Tech., Dubuque, IA, USA) at excitation and
emission wavelengths of 490 and 590 nm, respectively.
Cell line and mice
The human lung carcinoma cell line A549 was cultured
in RPMI 1640 medium supplemented with 10% fetal bo-
vine serum (FBS), 50 units/ml penicillin-streptomycin, 2
mM L-glutamine, 1 mM sodium pyruvate, 2 mM non-
essential amino acids, and 0.4 mg/ml G418. The cell cul-
ture was sustained at 37°C in a 5% CO2 incubator, and
the cells were maintained in the exponential growth
phase. Male BALB/c nu/nu nude mice (5 weeks old, 20
to 22 g) were purchased from Japan SLC Inc. (Hamamatsu,
Shizuoka, Japan). All procedures involving animals were
performed according to approved protocols and in ac-
cordance with the recommendations specified in the
NIH guidelines for proper use and care of laboratory
animals.
Flow cytometry analysis
A549 cells were plated in a 6-well plate at a density of
2 × 105 cells per well and cultured in medium supple-
mented with 10% FBS and 1% penicillin (Life Technologies,
Carlsbad, CA, USA) at 37°C. Culture medium was replacedwith 2 ml per well of culture medium containing lipo-
somal solutions (30 μg DOX/ml). The cells were incu-
bated with liposomes for 2 h at 37°C in a 5% CO2
incubator. After incubation, the cells were washed three
times with phosphate-buffered saline (PBS). The intra-
cellular uptake efficiency of liposomes by A549 cells
was monitored by flow cytometry (FACScan, Becton
Dickinson, Franklin Lakes, NJ, USA) using CELLQuest
software (Becton Dickinson Immunocytometry System,
Mountain View, CA, USA), and the morphology of
tumor cells containing DOX-loaded liposomes was ob-
served by fluorescence microscopy (Olympus CKX 41,
Shinjuku-ku, Tokyo, Japan).
Cytotoxicity test
The cytotoxicity of liposomes in A549 cells was deter-
mined by MTT assay. A549 cells were seeded into 96-well
plates at a density of 1 × 103 cells per well and cultured in
liposomal solution containing culture medium 37°C for a
predetermined time. The absorbance was measured at 590
nm using a microplate reader (EL808, Bio-Tek, Instru-
ments, Winooski, VT, USA).
Localization of DSPE-PEI liposomes in tumor tissue
A549 (1 × 106) cells were subcutaneously injected into
BALB/c nu/nu nude mice. Four weeks after injection,
free calcein was used as a model drug or liposomal cal-
cein was injected intratumorally into the mice, after
which the tumor tissue was monitored continuously for
4 h. The localization efficiency of liposomes in tumor
tissues of the live tumor-bearing mice was directly ob-
served under a fluorescence microscope (Macro-Imaging
System Plus LT-9macimstsplus, Lightools Research,
Encinitas, CA, USA) equipped with Image-Pro Plus
software (Media Cybernetics, Silver Spring, MD, USA).
Results and discussion
DSPE-PEI synthesis
The synthesis of DSPE-PEI conjugate was confirmed by
proton NMR analysis. Figure 1 shows the chemical struc-
tures and 1H-NMR spectra of the synthesized DSPE-PEI
conjugate. As shown in Figure 1B, peaks corresponding to
the CH3 (1) and CH2 (2,3, and 4) protons were observed
at 0.8 to 1.0 ppm (1), 1.1 to 1.4 ppm (2), 2.1 to 2.3 ppm
(3), and 3.7 to 3.8 ppm (4), respectively. In addition, the
PEI peaks were observed at 2.5 to 3.5 ppm. The synthesis
yield was approximately 93%.
Characteristics of liposomes
The physical properties of DSPE-PEI liposomes are
shown in Figure 2. The mean particle size of DSPE-PEI
liposomes was approximately 120 to 140 nm, and the
loading efficiency of DOX was 90% to 93% (Figure 2A,B).
The particle size and loading efficiency of liposomal
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size is an important factor for penetration of liposomes
into cells or organs [24]. Raasmaja et al. reported that
smaller (MW 22 kDa) linear PEI-attached liposomes were
more effective in gene transfection than larger (MW 25
kDa) branched PEI-attached liposomes and that particle
size also decreased when linear PEI polymer was used in-
stead of branched PEI [25]. In this study, small (MW 10
kDa) linear PEI polymers were used and therefore, the PEI
concentration on the liposomal surface may not affect the
particles size. DSPE-PEI liposomes were found to be uni-
form in size and small enough for efficient tissue and
cell penetration. The zeta potential of DSPE-PEI lipo-
somes changed from −35 to 30 mV with the addition of
PEI (Figure 2C), demonstrating that the addition of the
cationic lipid onto the liposomal surface induced a
positive surface charge on the liposomes. A PEI content
of as much as 0.4 mg, however, resulted in a leveled off
surface charge, indicating that the surface of the lipo-
somes may have been saturated at a PEI concentration
of 0.4 mg. Positively charged vehicles exhibit enhanced
intracellular delivery via an electro-binding effect be-
tween the positive liposomal surface and negative cell
surface [11] and therefore, surface charge is also an im-
portant factor in the efficacy of intracellular delivery of
liposomes.
Intracellular delivery of DSPE-PEI liposomes
Next, the intracellular uptake of liposomes with different
surface charges was assessed. The intracellular uptake
was measured and monitored using flow cytometry and
fluorescence microscopy, respectively (Figure 3). While
control (DSPE) liposomes exhibited low intracellular de-
livery efficiency (0.5%) because of the negatively charged
liposomal surface, DSPE-PEIs exhibited increased intra-



























Figure 2 Physical properties of liposomes. Liposome size (A), loading e
Control represents DSPE liposomes. PEI-1, PEI-2, PEI-3, and PEI-4 represent P
formulations, respectively. Data shown represent means ± SD (n = 3).liposomes. Notably, the intracellular uptake of DSPE-
PEI-2 liposomes was significantly higher than that of
control liposomes (p < 0.01, Figure 3A). These findings
indicate that an effective attachment took place between
the cationic DSPE-PEI liposomes and the negatively
charged cell surface and that the intracellular uptake of
liposomes was enhanced by the electric interaction of li-
posomes with tumor cells [11,25]. Based on these re-
sults, DSPE-PEI-2 (0.4 mg of DSPE-PEI) liposomes were
selected for further study. In addition, we check the
intracellular uptake of liposomes in tumor cell by fluor-
escence microscopy (Figure 3B). The uptake of DSPE-
PEI-2 liposomes by tumor cells was considerably higher
than that of control liposomes. This result further sup-
ports our hypothesis by demonstrating an electric inter-
action between a negatively charged tumor cell surface
and positively charged DSPE-PEI-2 liposomes.
Cytotoxicity assay
Prior to assessing the in vivo localization of DSPE-PEI-2 li-
posomes, the in vitro cytotoxicity of free DOX (positive con-
trol), control liposomes (negative control), and DSPE-PEI-2
liposomes was measured in A549 cells using an MTT assay
(Figure 4). Free DOX was found to be more cytotoxic to
A549 cells than liposomal DOX due to the higher cellular
uptake of free DOX by tumor cells via diffusion mechanisms
[26,27]. Furthermore, DSPE-PEI-2 (cationic liposomes) also
showed significantly higher cytotoxicity compared to control
liposomes (p < 0.01). The lower cytotoxicity of control lipo-
somes may be a result of their low intracellular uptake. Cel-
lular uptake of negatively charged control liposomes was
inhibited as demonstrated by the measured zeta potential
(Figure 2C) and by the flow cytometric study (Figure 3A).
DSPE-PEI-2 liposomes, on the other hand, do interact elec-
trostatically with A549 cell membranes, resulting in in-


















fficiency of DOX (B), and zeta potential of the liposomal surface (C).






























Figure 3 Intracellular uptake of liposomes. (A) Flow cytometric
assessment of the intracellular delivery of liposomes to tumor cells.
(B) Assessment of the intracellular uptake of liposomes by A549
tumor cells using fluorescence microscopy. PEI-1, PEI-2, PEI-3, and
PEI-4 represent PEI contents of 10%, 40%, 70%, and 100% (w/w total
lipid) in liposomal formulations, respectively. Error bar represents
mean ± SD (n = 3); *p < 0.001.
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The possible role of cationic charge in enhancing the ac-
cumulation of liposomes in tumor tissue was assessed by
fluorescence microscopy. Figure 5 shows the localization
of free calcein, control liposomes (negative charge), and
DSPE-PEI-2 liposomes (positive charge) in tumor-bearing
mice after intratumoral injection. As shown in Figure 5,
the image of DSPE-PEI-2 liposomes exhibits prominent
fluorescence 10 min after injection, and DSPE-PEI-2 li-
posomes at the tumor site show a longer retention time
(240 min) than either control liposomes or free calcein.


















Figure 4 Cytotoxicity after liposomal DOX uptake in A549 cells.
Error bar represents mean ± SD (n = 3); *p < 0.05.with cationic liposomes, specifically with DSPE-PEI-2
liposomes, may occur electrostatically between the
negative cell surfaces and positive DSPE-PEI-2 lipo-
somes. The observed effect is likely a result of the sur-
face charge of the cationic liposomes that were not
taken up by the tumor tissue, resulting in an enhance-
ment of the localization efficiency of the cationic lipo-
somes. Toward increasing the localization of payloads,
extensive research investigation has been carried out
into methods of modifying various carriers including
ligand-labeled liposomes [28], hydrogel-based intratu-
moral injections [7], and magnetic-based carriers [29].
Although these investigations have yielded promising
results, the additional formulations of such carrier sys-
tems require optimization.
Conclusions
Intratumoral injection is an effective method for liposome-
mediated drug delivery into tumor tissues. The use of
DOX-loaded DSPE-PEI cationic liposomes was found to
result in significantly increased in vitro intracellular uptake
compared with control liposomes. Notably, the conjugation
of PEI to the liposomal membrane effectively improved the
localization of drug-loaded liposomes at the tumor site
through electrostatic interaction, which occurred in the
tumor tissue of tumor-bearing mice treated with intratu-
morally injected liposomes. Our results demonstrate a
promising approach to improve the intracellular uptake
and localization effect of cationic liposomes. Although
DSPE-PEI liposomes exhibit enhanced intracellular uptake,
additional studies on the localization, injection route, and
stability of these carriers is required for validation of their
potential clinical application. The cationic liposome deliv-
ery strategy presented here has considerable potential as aFigure 5 Fluorescence microscopy images of liposomal calcein
in A549 tumor-bearing mice following intratumoral injection.
Localization of liposomes in the tumor tissue was directly observed
by fluorescence microscopy in live tumor-bearing mice.
Han et al. Nanoscale Research Letters 2014, 9:209 Page 6 of 6
http://www.nanoscalereslett.com/content/9/1/209drug delivery platform for the treatment of a broad range
of human diseases and can be adapted for other injection
applications in various therapeutic fields.
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